Neogen (NEOG) EBITDA Margin (2010 - 2026)
Neogen's (NEOG) quarterly EBITDA Margin came in at 1.56% in Q1 2026, down 401.0% year-on-year from 0.52% in Q1 2025, and up 34.71% quarter-over-quarter from 2.39% in Q4 2025.
Neogen (NEOG) EBITDA Margin (2010 - 2026) Analysis & Trends
Neogen's EBITDA Margin history runs 17 years deep, the most recent figure standing at 1.56% for Q1 2026.
- On a quarterly basis, EBITDA Margin fell 401.0% year-over-year to 1.56% in Q1 2026; TTM through Feb 2026 was 73.05%, a 2484.0% decrease from a year earlier, with the FY2025 full-year figure at 118.59%, down 12494.0% from the prior year.
- EBITDA Margin improved to 1.56% in Q1 2026 per NEOG's latest filing, from 2.39% in the prior quarter.
- Across five years, EBITDA Margin topped out at 12.87% in Q2 2022 and bottomed at 271.09% in Q2 2025.
- The 5-year median for EBITDA Margin is 4.58% (2022), against an average of 24.45%.
- Biggest YoY gain for EBITDA Margin was 19543 bps in 2025; the steepest drop was 27659 bps in 2025.
- Year by year, EBITDA Margin stood at 3.33% in 2022, then jumped by 289 bps to 6.3% in 2023, then sank by 3240 bps to 197.82% in 2024, then jumped by 99 bps to 2.39% in 2025, then surged by 35 bps to 1.56% in 2026.
- Per Business Quant, the three latest NEOG EBITDA Margin figures stand at 1.56% (Q1 2026), 2.39% (Q4 2025), and 7.69% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -1.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.56% |
| Nov 30, 2025 | -2.39% |
| Aug 31, 2025 | -7.69% |
| May 31, 2025 | -271.09% |
| Feb 28, 2025 | 2.44% |
| Nov 30, 2024 | -197.82% |
| Aug 31, 2024 | 1.04% |
| May 31, 2024 | 5.51% |
| Feb 29, 2024 | 5.25% |
| Nov 30, 2023 | 6.30% |
| Aug 31, 2023 | 8.36% |
| May 31, 2023 | 9.69% |
| Feb 28, 2023 | 7.19% |
| Nov 30, 2022 | -3.33% |
| Aug 31, 2022 | 4.58% |
| May 31, 2022 | 12.87% |
| Feb 28, 2022 | 4.97% |
| Nov 30, 2021 | 9.55% |
| Aug 31, 2021 | 16.95% |
| May 31, 2021 | 15.90% |